Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor.
Open Access
- 1 February 1994
- Vol. 35 (2) , 215-219
- https://doi.org/10.1136/gut.35.2.215
Abstract
Previous studies have shown that: (a) platelet activating factor induces shock and intestinal injury, (b) exogenous platelet activating factor stimulates synthesis of endogenous platelet activating factor, and (c) tumour necrosis factor alpha and endotoxin synergise to induce shock and bowel injury in animals. These last two effects are largely mediated by platelet activating factor forming phospholipase A2 A2, a key enzyme for platelet activating factor synthesis, was examined in mouse intestine. It was found that tumour necrosis factor alpha and endotoxin synergise to stimulate platelet activating factor forming phospholipase A2 activity in the intestine, as well as platelet activating factor production, and these effects were blocked by pretreatment with platelet activating factor antagonists, SRI-63-441 and WEB 2086. In addition, exogenous platelet activating factor stimulates intestinal phospholipase A2 activity. These results show that tumour necrosis factor alpha and lipopolysaccharide synergistically activate the phospholipase A2 that participates in platelet activating factor formation, and this activation is largely mediated by endogenous platelet activating factor. Furthermore, platelet activating factor itself increases phospholipase A2 activity, suggesting that platelet activating factor induces its own synthesis, probably by phospholipase A2 activation.Keywords
This publication has 38 references indexed in Scilit:
- Tumor necrosis factor-α/cachectin activates the O2−-generating system of human neutrophils independently of the hydrolysis of phosphoinositides and the release of arachidonic acidBiochemical and Biophysical Research Communications, 1990
- Effect of tumor necrosis factor on granule release and LTB4 production in adherent human polymorphonuclear leukocytesInflammation Research, 1989
- Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1989
- Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Journal of Clinical Investigation, 1988
- Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.Journal of Clinical Investigation, 1988
- Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Pathogenesis of hypotension in septic shockCritical Care Medicine, 1988
- Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolismBiochemical and Biophysical Research Communications, 1987
- Effect of platelet-activating factor on arachidonic acid metabolism in renal epithelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Phospholipase A2 activity of lysosomal origin secreted by polymorphonuclear leucocytes during phagocytosis or on treatment with calciumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981